Reuters logo
17 days ago
BRIEF-Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial
July 10, 2017 / 1:30 AM / 17 days ago

BRIEF-Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial

1 Min Read

July 10 (Reuters) - Prima Biomed Ltd

* Received regulatory and ethical approvals for clinical trial investigating IMP321 in new settings, called Insight​

* Approval has been received from Paul-Ehrlich-Institut, Federal Institute For Vaccines And Biomedicines For German Federal Ministry Of Health Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below